Abstract
l-Asparaginase is an important component in the treatment of acute lymphoblastic leukemia in children. Its antineoplastic activity toward malignant cells is due to their characteristic nature in slow synthesis of l-asparagine (Asn), which causes starvation for this amino acid, while normal cells are protected from Asn starvation due to their ability to produce this amino acid. The relative selectivity with regard to the metabolism of malignant cells forces to look for novel asparaginase with little glutaminase-producing systems compared to existing enzyme. In this investigation, the role of the extracellular asparaginase enzyme produced by an isolated bacterial strain was studied. Biochemical characterization denoted that this isolated bacterial strain belongs to the Bacillus circulans species. The strain was tested for l-asparaginase production, and it was observed that, under an optimized environment, this isolate produces a maximum of 85 IU ml−1 within 24-h incubation. This enzyme showed less (60%) glutaminase activity compared to commercial Erwinia sp. l-asparaginase. The partially purified enzyme showed an approximate molecular weight of 140 kDa. This enzyme potency in terms of antineoplastic activity was analyzed against the cancer cells, CCRF-CEM. Flow cytometry experiments indicated an increase of sub-G1 cell population when the cells were treated with l-asparaginase.
Similar content being viewed by others
Reference
Kristiansen, T., Einarsson, M., Sundberg, L., & Porath, J. (1970). FEBS Letters, 7(3), 294–296. doi:10.1016/0014-5793(70)80186-7.
Lee, S. M., Wroble, M. H., & Ross, J. T. (1989). Applied Biochemistry and Biotechnology, 22, 1–11. doi:10.1007/BF02922693.
Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., et al. (2002). Blood, 99, 2734–2739. doi:10.1182/blood.V99.8.2734.
Broome, J. D. (1961). Nature, 191, 1114–1115. doi:10.1038/1911114a0.
Yellin, T. O., & Wriston, J. C. (1966). Biochemistry, 5, 1605–1612. doi:10.1021/bi00869a022.
Mashburn, L., & Wriston, J. C. (1964). Archives of Biochemistry and Biophysics, 105, 450–452. doi:10.1016/0003-9861(64)90032-3.
Campbell, H., & Mashburn, L. (1969). Biochemistry, 9, 3768–3775. doi:10.1021/bi00837a042.
Ho, D., Thetford, B., Carter, C., & Frei, E. (1978). Clinical Pharmacology and Therapeutics, 11, 408–417.
Sarquis, M. I. D. M., Oliveira, E. M. M., Santos, A. S., & da Costa, G. L. (2004). Mem Inst Oswaldo Cruz, Rio de Janeiro, 99, 489–492.
Swain, A. L., Jaskolski, M., Housset, D., Mohana Rao, J. K., & Wlodawer, A. (1993). Proc. Natl Acad Sci USA, 90, 1474–1478. doi:10.1073/pnas.90.4.1474.
Cornea, C. P., Lupescu, I., Vatafu, I., Savoiu, V. G., & Campeanu, G. H. (2000). Roum. Biotechnology Letters, 5, 471–478.
Liu, F. S., & Zajic, J. E. (1973). Applied Microbiology, 25, 92–96.
Manna, S., Sinha, A., Sadhukhan, R., & Chakrabarty, S. L. (1995). Current Microbiology, 30, 291–298. doi:10.1007/BF00295504.
Abdel-Fattah, Y. R., & Olama, Z. A. (2002). Process Biochem, 38, 115–122. doi:10.1016/S0032-9592(02)00067-5.
Radcliffe, C. W., Kafkewitz, D., & Abuchowski, A. (1979). Applied and Environmental Microbiology, 38, 761–762.
Prakasham, R. S., Subba Rao, Ch, Sreenivas Rao, R., Suvarna Lakshmi, G., & Sarma, P. N. (2007). J Appl. Microbiol., 102, 1382–1391. doi:10.1111/j.1365-2672.2006.03173.x.
Wriston, J. C., & Yellin, T. O. (1973). Advances in Enzymology, 39, 185–248. doi:10.1002/9780470122846.ch3.
Eden, O. B., Shaw, M. P., Lilleyman, J. S., & Richards, S. (1990). Medical and Pediatric Oncology, 18, 497–502. doi:10.1002/mpo.2950180612.
Asselin, B. L., Lorenson, M. Y., & Whitin, J. C. (1993). Journal of Clinical Oncology, 11, 1780–1786.
Laemmli, U. K. (1970). Nature, 227, 680–685. doi:10.1038/227680a0.
Mosmann, T. (1988). Journal of Immunological Methods, 65, 55–63. doi:10.1016/0022-1759(83)90303-4.
Jackon, R. D., & Handschumacher, R. E. (1970). Biochemistry, 9, 3585–3590. doi:10.1021/bi00820a013.
Maita, T., & Matsuda, G. (1980). Hoppe-Seyler’s Zeitschrift fur Physiologische Chemie, 361, 105–117.
Kiriyama, Y., Kubota, M., Takimoto, T., et al. (1989). Leukemia, 3, 294–297.
Prager, M. D., & Bachynsky, N. (1968). Biochemical and Biophysical Research Communications, 31, 43–47. doi:10.1016/0006-291X(68)90028-4.
Asselin, B. L., Ryan, D., & Frantz, C. N. (1989). Cancer Research, 49, 4363–4369.
Ueno, T., Ontawa, K., Mitusi, K., et al. (1977). Leukemia, 11, 1858–1861. doi:10.1038/sj.leu.2400834.
Shimizu, T., Kubota, M., & Adachi, S. (1992). International Journal of Cancer, 50, 644–648. doi:10.1002/ijc.2910500427.
Kurtzberg, J., Yousem, D., & Beauchamp, N. (2003). Cancer Medicine (Vol. IV, pp. 699–705). USA: American Cancer Society. section 13 (Edited by J Holland, E Fries, J Kurtzberg).
Chemocare.com. http://www.chemocare.com/bio/erwinia_lasparaginase.asp
Acknowledgments
Authors, Mr Ch Subba Rao and M Hymavathi, are thankful for the financial support in the form of fellowship from CSIR and UGC, respectively.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prakasham, R.S., Hymavathi, M., Subba Rao, C. et al. Evaluation of Antineoplastic Activity of Extracellular Asparaginase Produced by Isolated Bacillus circulans . Appl Biochem Biotechnol 160, 72–80 (2010). https://doi.org/10.1007/s12010-009-8679-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-009-8679-8